替卡格雷
医学
氯吡格雷
普拉格雷
阿司匹林
冲程(发动机)
潘生丁
血小板聚集抑制剂
抗血小板药物
心脏病学
内科学
重症监护医学
机械工程
工程类
作者
Rahul Chandra,Harneel Saini,Russell Cerejo,Ashis Tayal,Konark Malhotra
摘要
Abstract: Antiplatelet medications are the mainstay for secondary stroke treatment. Aspirin, clopidogrel, and aspirin-dipyridamole are commonly used antiplatelet medications. Other antiplatelet medications such as ticagrelor and prasugrel have been majorly used in cardiovascular or neuro-interventional specialties. Recent studies have paved a way to their use in secondary stroke prevention. In this review, we have briefly discussed the pharmacology of ticagrelor, published literature in cardiology and stroke trials, use of ticagrelor among patients with ischemic strokes, and compared its efficacy, limitations and side-effects with other antiplatelet medications. Keywords: Ticagrelor, stroke, clopidogrel, platelet inhibition
科研通智能强力驱动
Strongly Powered by AbleSci AI